Long-chain saturated fatty acid species are not toxic to human pancreatic β-cells and may offer protection against pro-inflammatory cytokine induced β-cell death

Long-chain saturated fatty acid species are not toxic to human pancreatic β-cells and may offer protection against pro-inflammatory cytokine induced β-cell death

Weight problems is a significant danger issue for sort 2 diabetes (T2D) though the causal hyperlinks stay unclear. A function shared by each circumstances nonetheless is systemic irritation and raised ranges of circulating fatty acids (FFA). It’s broadly believed that in overweight people genetically liable to T2D, elevated ranges of plasma FFA might contribute in the direction of the dying and dysfunction of insulin-producing pancreatic β-cells in a means of (gluco)lipotoxicity.

In assist of this, in vitro research have proven persistently that long-chain saturated fatty acids (LC-SFA) are poisonous to rodent β-cells throughout persistent publicity (> 24 h). Conversely, shorter chain SFA and unsaturated species are nicely tolerated, suggesting that toxicity depends on carbon chain size and/or double bond configuration. Regardless of the wealth of proof implicating lipotoxicity as a method of β-cell dying in rodents, the proof {that a} comparable course of happens in people is far much less substantial. Subsequently, the current examine has evaluated the results of persistent publicity to fatty acids of various chain size and diploma of saturation, on the viability of human β-cells in tradition.

We now have additionally studied the results of a mix of fatty acids and pro-inflammatory cytokines. Strikingly, we discover that LC-FFA don’t readily promote the demise of human β-cells and that they might even supply a measure of safety towards the poisonous results of pro-inflammatory cytokines. Subsequently, these findings indicate {that a} mannequin wherein elevated circulating LC-FFA play a direct function in mediating β-cell dysfunction and dying in people, could also be overly simplistic.

Enriching for human acute myeloid leukemia stem cells utilizing reactive oxygen species-based cell sorting

Isolation of leukemia stem cells presents a problem as a result of heterogeneity of the immunophenotypic markers generally used to establish blood stem cells. A number of research have reported that relative ranges of reactive oxygen species (ROS) can be utilized to complement for stem cell populations, suggesting a possible different to floor antigen-based strategies.

Right here, we describe a protocol to complement for stem cells from human acute myeloid leukemia specimens utilizing relative ranges of ROS. This protocol offers constant enrichment of leukemia stem cells. For full particulars on the use and execution of this protocol, please confer with Lagadinou et al. (2013) and Pei et al. (2018).

Long-chain saturated fatty acid species are not toxic to human pancreatic β-cells and may offer protection against pro-inflammatory cytokine induced β-cell death

Substrate Stiffness, Cell Anisotropy, and CellCell Contact Contribute to Enhanced Structural and Calcium Dealing with Properties of Human Embryonic Stem Cell-Derived Cardiomyocytes

Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) will be utilized to know the mechanisms underlying the event and development of coronary heart illness, in addition to to develop higher interventions and coverings for this illness. Nonetheless, these cells are structurally and functionally immature, which undermines a few of their adequacy in modeling grownup coronary heart tissue.

Earlier research with immature cardiomyocytes have proven that altering substrate stiffness, cell anisotropy, and/or cell-cell contact can improve the contractile and structural maturation of hPSC-CMs. On this examine, the structural and calcium dealing with properties of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) have been enhanced by publicity to a downselected mixture of those three maturation stimuli. First, hESC-CMs have been seeded onto substrates composed of two business formulations of polydimethylsiloxane (PDMS), Sylgard 184 and Sylgard 527, whose stiffness ranged from 5 kPa to 101 kPa. Upon analyzing the morphological and calcium transient properties of those cells, it was concluded {that a} 21 kPa substrate yielded cells with the best diploma of maturation.

Subsequent, these PDMS substrates have been microcontact-printed with laminin to pressure the classy cells into rod-shaped geometries utilizing line patterns that have been 12, 18, or 24 μm in width. We discovered that cells on the 18 and 24 μm sample widths had structural and useful properties that have been superior to these on the 12 μm sample.

The hESC-CMs have been then seeded onto these line-stamped surfaces at a density of 500 000 cells per 25-mm-diameter substrate, to allow the formation of cell-cell contacts at their distal ends. We found that this mixture of tradition circumstances resulted in cells that have been extra structurally and functionally mature than those who have been solely uncovered to at least one or two stimuli. Our outcomes recommend that downselecting a mix of mechanobiological stimuli may show to be an efficient technique of maturing hPSC-CMs in vitro.

Laser-Primarily based Hybrid Manufacturing of Endosseous Implants: Optimized Titanium Surfaces for Enhancing Osteogenic Differentiation of Human Mesenchymal Stem Cells

Additive manufacturing (AM) is turning into more and more vital within the orthopedic and dental sectors thanks to 2 main benefits: the potential of customized manufacturing and the combination of advanced buildings. Nonetheless, at smaller scales, floor circumstances of AM merchandise are usually not mastered. Quite a few non-fused powder particles give rise to roughness values (Sa) higher than 10 μm, thus limiting biomedical purposes for the reason that floor roughness of, e.g., metallic implants performs a significant function within the high quality and charge of osseointegration.

On this examine, an progressive hybrid machine combining AM and a femtosecond laser (FS) was used to acquire Ti6Al4V elements with biofunctional surfaces. In the course of the manufacturing course of, the FS laser beam “neatly” ablates the floor, leaving in its path nanostructures created by the laser/matter interplay. This step decreases the Sa from 11 to four μm and will increase the floor wettability.

The conduct of human mesenchymal stem cells was evaluated on these new AM+FS surfaces and in contrast with that on AM surfaces and likewise on polished surfaces. The variety of cells hooked up 24 h after plating is equal on all surfaces, however cell spreading is greater on AM+FS surfaces in contrast with their AM counterparts. In the long term (days 7 and 14), fibronectin and collagen synthesis improve on AM+FS surfaces versus AM alone.

Alkaline phosphatase exercise, osteocalcin manufacturing, and mineralization, markers of osteogenic differentiation, are considerably decrease on uncooked AM surfaces, whereas on the AM+FS specimens they show a degree equal to that on the polished floor. Total, these outcomes point out that utilizing an FS laser beam through the fabrication of AM elements optimizes floor morphology to favor osteoblastic differentiation.

T-cell Surface Glycoprotein CD1b (CD1B) Antibody

abx030324-400ul 400 ul
EUR 627.6

T-cell Surface Glycoprotein CD1b (CD1B) Antibody

abx030324-80l 80 µl
EUR 343.2

T-cell Surface Glycoprotein CD1b (CD1B) Antibody

20-abx320708
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

T-cell Surface Glycoprotein CD1b (CD1B) Antibody

20-abx006357
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

T-cell Surface Glycoprotein CD1b (CD1B) Antibody

20-abx009480
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Rabbit polyclonal antibody to CD1B (CD1B molecule)

TA308296 100 µl Ask for price

CD1b antibody

10R-6324 100 ug
EUR 249.6
Description: Mouse monoclonal CD1b antibody

CD1B antibody

22413-100ul 100ul
EUR 468

CD1B antibody

70R-13508 100 ul
EUR 548.4
Description: Affinity purified Rabbit polyclonal CD1B antibody

CD1b antibody

70R-49494 100 ul
EUR 292.8
Description: Purified Polyclonal CD1b antibody

CD1B Antibody

46433-100ul 100ul
EUR 302.4

CD1B Antibody

ABD10150 100 ug
EUR 525.6

CD1B Antibody

1-CSB-PA004890ESR2HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against CD1B. Recognizes CD1B from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

CD1b Antibody

F46544-0.08ML 0.08 ml
EUR 140.25
Description: This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to late endosomes and lysosomes via a tyrosine-based motif in the cytoplasmic tail, and requires vesicular acidification to bind lipid antigens. [provided by RefSeq].

CD1b Antibody

F46544-0.4ML 0.4 ml
EUR 322.15
Description: This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to late endosomes and lysosomes via a tyrosine-based motif in the cytoplasmic tail, and requires vesicular acidification to bind lipid antigens. [provided by RefSeq].

CD1B Antibody

E046433 100μg/100μl
EUR 255
Description: Available in various conjugation types.

CD1B Antibody

E10-31418 100ul
EUR 225
Description: Available in various conjugation types.

CD1B Antibody

E10-31419 100ul
EUR 225
Description: Available in various conjugation types.

CD1B Antibody

E19-10150-1 50ug/50ul
EUR 145
Description: Available in various conjugation types.

CD1B Antibody

E19-10150-2 100ug/100ul
EUR 225
Description: Available in various conjugation types.

CD1b Antibody

V2950-100UG 100 ug
EUR 349.3
Description: The mouse monoclonal antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin (Workshop IV; Code T015). It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1B molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. CD1B is also expressed in interdigitating cells.

CD1b Antibody

V2950-20UG 20 ug
EUR 153.3
Description: The mouse monoclonal antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin (Workshop IV; Code T015). It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1B molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. CD1B is also expressed in interdigitating cells.

CD1b Antibody

V2950SAF-100UG 100 ug
EUR 349.3
Description: The mouse monoclonal antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin (Workshop IV; Code T015). It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1B molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. CD1B is also expressed in interdigitating cells.

CD1b Antibody

V2028-100UG 100 ug
EUR 349.3
Description: This antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin. It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1b molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. It is also expressed in interdigitating cells.

CD1b Antibody

V2028-20UG 20 ug
EUR 153.3
Description: This antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin. It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1b molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. It is also expressed in interdigitating cells.

CD1b Antibody

V2028SAF-100UG 100 ug
EUR 349.3
Description: This antibody recognizes CD1b, a 44kDa type I glycoprotein associated with beta2-microglobulin. It is expressed on dendritic cells, Langerhans cells, thymocytes, and T acute lymphoblastic leukemia cells. The CD1 multigene family encodes five forms of the CD1 T-cell surface glycoprotein in human, designated CD1A, 1B, 1C, 1D and 1E. CD1, a type 1 membrane protein, has structural similarity to the MHC class I antigen and has been shown to present lipid antigens for recognition by T lymphocytes. Constitutive endocytosis of CD1b molecules and the differential sorting of MHC class II from lysosomes separate peptide- and lipid antigen-presenting molecules during dendritic cell maturation. It is also expressed in interdigitating cells.

CD1b Antibody

RQ4547 100ug
EUR 356.15
Description: CD1b is a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to late endosomes and lysosomes via a tyrosine-based motif in the cytoplasmic tail, and requires vesicular acidification to bind lipid antigens.

CD1B Antibody

E309888 100ug/200ul
EUR 295
Description: Available in various conjugation types.

CD1B Antibody

DF10150-100ul 100ul
EUR 280

CD1B Antibody

DF10150-200ul 200ul
EUR 350

CD1B Antibody

DF10150 100ul
EUR 280
Description: Human,Rat

CD1B antibody

22413 100ul
EUR 479

CD1B Antibody

46433 100ul
EUR 319

T-cell Surface Glycoprotein CD1b (CD1B) Antibody (PE)

abx140369-100tests 100 tests
EUR 577.2

Lenti ORF particles, CD1B (mGFP-tagged) - Human CD1b molecule (CD1B), 200ul, >10^7 TU/mL

RC219131L4V 200 µl Ask for price

Lenti ORF particles, CD1B (Myc-DDK tagged) - Human CD1b molecule (CD1B), 200ul, >10^7 TU/mL

RC219131L3V 200 µl Ask for price

CD1B Rabbit pAb

A6551-100ul 100 ul
EUR 369.6

CD1B Rabbit pAb

A6551-200ul 200 ul
EUR 550.8

CD1B Rabbit pAb

A6551-20ul 20 ul
EUR 219.6

CD1B Rabbit pAb

A6551-50ul 50 ul
EUR 267.6

CD1B Rabbit pAb

E2516551 100ul
EUR 225
Description: Available in various conjugation types.

CD1B Rabbit pAb

E2251757 100ul
EUR 225
Description: Available in various conjugation types.

Human T- cell surface glycoprotein CD1b, CD1B ELISA KIT

ELI-50259h 96 Tests
EUR 988.8

CD1b(100-1A5) Antibody

BNC941044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF594 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC941044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF594 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC801044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF680 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC801044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF680 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC811044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF680R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC811044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF680R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC701044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF770 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC701044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF770 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC881044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF488A conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC881044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF488A conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC051044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF405M conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC051044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF405M conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC041044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF405S conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC041044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF405S conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC401044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF640R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC401044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF640R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNCB1044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), Biotin conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNCB1044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), Biotin conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNCAP1044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNCAP1044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNCA1044-250 250uL
EUR 459.6
Description: Primary antibody against CD1b(100-1A5), APC conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNCR1044-250 250uL
EUR 459.6
Description: Primary antibody against CD1b(100-1A5), RPE conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNCP1044-250 250uL
EUR 459.6
Description: Primary antibody against CD1b(100-1A5), PerCP conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNUM1044-50 50uL
EUR 474
Description: Primary antibody against CD1b(100-1A5), 1mg/mL

CD1b(100-1A5) Antibody

BNCH1044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNCH1044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNUB1044-100 100uL
EUR 250.8
Description: Primary antibody against CD1b(100-1A5), Concentration: 0.2mg/mL

CD1b(100-1A5) Antibody

BNUB1044-500 500uL
EUR 549.6
Description: Primary antibody against CD1b(100-1A5), Concentration: 0.2mg/mL

CD1b(100-1A5) Antibody

BNC611044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF660R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC611044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF660R conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC551044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF555 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC551044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF555 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC431044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF543 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC431044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF543 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC681044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF568 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC681044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF568 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC471044-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(100-1A5), CF647 conjugate, Concentration: 0.1mg/mL

CD1b(100-1A5) Antibody

BNC471044-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(100-1A5), CF647 conjugate, Concentration: 0.1mg/mL

Human T-cell surface glycoprotein CD1b(CD1B) ELISA kit

CSB-EL004890HU-24T 1 plate of 24 wells
EUR 198
Description: Quantitativesandwich ELISA kit for measuring Human T-cell surface glycoprotein CD1b (CD1B) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human T-cell surface glycoprotein CD1b(CD1B) ELISA kit

1-CSB-EL004890HU
  • EUR 964.80
  • EUR 6118.80
  • EUR 3244.80
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Human T-cell surface glycoprotein CD1b(CD1B) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Rabbit T- cell surface glycoprotein CD1b, CD1B ELISA KIT

ELI-10666Ra 96 Tests
EUR 1113.6

Human T-cell surface glycoprotein CD1b(CD1B) Elisa Kit

EK711781 96 Wells
EUR 0.2

CD1b Antibody (FITC)

abx139085-100tests 100 tests
EUR 510

CD1b(RIV12) Antibody

BNCA0317-250 250uL
EUR 459.6
Description: Primary antibody against CD1b(RIV12), APC conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC800317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF680 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC800317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF680 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC810317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF680R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC810317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF680R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC940317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF594 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC940317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF594 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC700317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF770 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC700317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF770 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC430317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF543 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC430317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF543 conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC400317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF640R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC400317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF640R conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC050317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF405M conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC050317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF405M conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNCB0317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), Biotin conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNCB0317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), Biotin conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNCAP0317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNCAP0317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC880317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF488A conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC880317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF488A conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNCR0317-250 250uL
EUR 459.6
Description: Primary antibody against CD1b(RIV12), RPE conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNCP0317-250 250uL
EUR 459.6
Description: Primary antibody against CD1b(RIV12), PerCP conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNUM0317-50 50uL
EUR 474
Description: Primary antibody against CD1b(RIV12), 1mg/mL

CD1b(RIV12) Antibody

BNCH0317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNCH0317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNUB0317-100 100uL
EUR 250.8
Description: Primary antibody against CD1b(RIV12), Concentration: 0.2mg/mL

CD1b(RIV12) Antibody

BNUB0317-500 500uL
EUR 549.6
Description: Primary antibody against CD1b(RIV12), Concentration: 0.2mg/mL

CD1b(RIV12) Antibody

BNC040317-100 100uL
EUR 238.8
Description: Primary antibody against CD1b(RIV12), CF405S conjugate, Concentration: 0.1mg/mL

CD1b(RIV12) Antibody

BNC040317-500 500uL
EUR 652.8
Description: Primary antibody against CD1b(RIV12), CF405S conjugate, Concentration: 0.1mg/mL

This new hybrid machine may make it attainable to provide AM implants with useful surfaces straight on the finish of AM, thereby limiting their post-treatments.

 

 

Related Posts

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *